Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter

National Medical Journal of China

Volumn 86, Issue 2, 2006, Pages 106-110

  Zhou, Hong Ke ^a   Yang, Dong Hua ^a   Tang, Shao Hui ^a   Huang, Wei ^a   Lu, Xiao Hua ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Carcinoma, hepatocellular; Insulin like growth factor II; Plasmids; Thymidine kinase

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GANCICLOVIR; MESSENGER RNA; PLASMID VECTOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN B; VIRUS FUSION PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL KILLING; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; FLUORESCENCE MICROSCOPY; GENE SEQUENCE; GENE TARGETING; GENETIC RECOMBINATION; GENETIC SCREENING; HELA CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SHUTTLE VECTOR; VIRAL GENE THERAPY;

ADENOVIRIDAE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; GANCICLOVIR; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDINE KINASE; TRANSFECTION;

EID: 31144463511     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Sussenbach JS. The gene structure of the insulin-like growth factor family. Prog Growth Factor, 1989, 1:33-48.
2. Pagter-Holthuizen P, Jansen M, van der Kammen RA, et al. Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. Biochim Biophys Acta, 1988, 950:282-295.
3. Fiorentino M, Grigioni WF, Baccarini P, et al. Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma. An in situ hybridization and immunohistochemical study. Diagn Mol Pathol, 1994,3:59-65.
4. Cariani E, Lasserre C, Kemeny F, et al. Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer. Hepatology, 1991, 13:644-649.
5. Niculescu-Duvaz D, Niculesru-Duvaz I, Springer CJ. Design of prodrugs for suicide gene therapy. Methods Mol Med, 2004, 90: 161-202.
6. Vassaux G, Martin-Duque P. Use of suicide genes for cancer gene therapy: study of the different approaches. Expert Opin Biol Ther, 2004,4:519-530.
7. Chinese source. 2001, 81:999-1003.
8. Chinese source. 2005,85:547-550.
9. Cao G, Kuriyama S, Gao J, et al. In vivo gene transfer of a suicide gene under the transcriptional control of the carcinoembryonic antigen promoter results in bone marrow transduction but can avoid bone marrow suppression. Int J Oncol, 1999, 15:107-112.
10. Chinese source. 2003, 19:1662-1666.